货号 HC669016 品牌 abinScience 描述
Pasotuxizumab (
HC669016 ) is a research-grade recombinant antibody targeting
CD3 . Produced in mammalian cells with native-like glycosylation.
Highlights
● Research Grade — For PK/PD studies, assay development, and ADA research.● Native Glycosylation — Mammalian expression ensures native-like patterns.
种属反应性 Human 应用 ELISA, Bioactivity: FACS, Functional assay, Research in vivo 宿主 Human 同种型 (scFv-heavy-kappa)-(scFv-heavy-lambda) 表达系统 Mammalian cells 克隆类型 Monoclonal 靶标 NAALAD1, Prostate-specific membrane antigen, NAALADase I, PSMA, PSM, Pteroylpoly-gamma-glutamate carboxypeptidase, Glutamate carboxypeptidase 2, N-acetylated-alpha-linked acidic dipeptidase I, Glutamate carboxypeptidase II, FOLH1, FGCP, FOLH, Folylpoly-gamma-glutamate carboxypeptidase, Folate hydrolase 1, GCPII, Membrane glutamate carboxypeptidase, Cell growth-inhibiting gene 27 protein, mGCP, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain 内毒素水平 < 10 EU/mg 纯度 >95% purity as determined by SDS-PAGE. 纯化方式 Purified by Nickel column. Accession号 Q04609 & P07766 状态 Liquid
保存溶液
0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
稳定性和存储 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. 别名 Bispecific, BAY2010112, BITEMT112, MT-112, 1442657-12-6 背景 Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research. Note For research use only. Not suitable for clinical or therapeutic use.
